Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

remdesivir_ulrich_perrey

India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020 Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …
News
chloroquine

Lancet expresses concern over published hydroxychloroquine and chloroquine paper

June 3, 2020 Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine

The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …
News
fda

The Association of American Physicians & Surgeons sue FDA to end restrictions on hydroxychloroquine, despite evidence it can be life threatening

June 3, 2020 Research and Development AAPS, COVID-19, coronaviryus

The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access …
News
ibuprofen

Kings College London launches trial investigating the effectiveness of ibuprofen in COVID-19 patients

June 3, 2020 Research and Development COVID-19, coronavirus, ibuprofen

Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 3, 2020 Research and Development COVID-19, coronavirus

COVID-19 treatments dominate the news this week as Russia is set to start its roll out of the anti-viral drug …
News
david_paul_morrisbloomberg

Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows

June 2, 2020 Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …
News
ipsen

Ipsen appoints David Loew as new Chief Executive Officer

June 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

David Loew will leave his position as the head of Sanofi’s vaccine division to become the Chief Executive Officer of …
Appointment

How Big Brother is helping to fight COVID-19

June 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, NHS, coronavirus, feeature, pharma, track and trace

Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …
Feature
putey

Russia to begin administering anti-viral COVID-19 drug next week

June 1, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Russia, coronavirus, pandemic, virus

Russia will start its roll out of the anti-viral drug Avifavir (favipiravir) to COVID-19 patients next week, according to the …
News
gilead-sciences

Gilead’s magrolimab shows promising responses in untreated myelodysplastic syndrome and acute myeloid leukaemia at ASCO 2020

June 1, 2020 Research and Development, Sales and Marketing ASCO 2020, Cancer, Gilead, leukaemia, magrolimab

Gilead took the opportunity at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to unveil new Phase 1b …
News
shutterstock_243110086

First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment

May 29, 2020 Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir

The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …
News
shutter

MSD and Eisai announce meaningful objective response rates for Keytruda+Lenvima combo in two cancer patient populations

May 29, 2020 Medical Communications, Research and Development Lenvima, keytruda, pharma

MSD has pulled back the curtain on new data from two trials of its anti-PD-1 immunotherapy Keytruda (pemvbrolizmuab) in combination …
News
martin_andrews

Evox appoints ex-GSK exec Martin Andrews as new non-Executive Director

May 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evox, GSK, appointment

Evox Therapeutics has named ex-GlaxoSmithKline executive Martin Andrews as its new non-Executive Director, it has emerged.   Andrews has previously …
Appointment
sergei_svarovsky

Axim Biotechnologies Inc announces Dr Sergei Svarovsky as Chief Scientific Officer of subsidiary Sapphire Biotech

May 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Axim Biotechnologies has announced that Dr Sergei Svarovsky will be the new Chief Scientific Officer of its subsidiary Sapphire Biotech. …
Appointment
fda

FDA approves Sanofi’s Dupixent for children with dermatitis

May 27, 2020 Research and Development Dupixent, Sanofi, atopic eczema

The FDA has approved Sanofi’s Dupixent (dupilumab) for children between ages 6 to 11 with moderate to severe atopic dermatitis. …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026